|
2
Votes
vote
New report on CEL-SCI's H1N1 flu drug candidateBioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published a new report about CEL-SCI Corporation's new H1N1 flu drug candidate. ... |
Login or Create your account on Keegy to send your comment.
Why should I get an account?
Get Keegy on your site
Put Keegy everywhere
Add buttons to know your online users , ranking position o your visitors vote your stories.
